Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Glioma × Particle Accelerators × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pelvic Neoplasms 1 Pancreatic Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Glioblastoma 1 Acute Toxic Effects 1

Interventions

Temozolomide 94 Magnetic Resonance Spectroscopy 45 Bevacizumab 45 Radiotherapy 39 Irinotecan 22 Blood Specimen Collection 15 Aminolevulinic Acid 14 Surgical Procedures, Operative 13 Radiation 13 Nivolumab 12 Carboplatin 12 Radiotherapy, Intensity-Modulated 10 Radiosurgery 10 Carmustine 10 pembrolizumab 9 fluorodopa F 18 9 Surveys and Questionnaires 8 Specimen Handling 8 Biopsy 8 poly ICLC 7 Topotecan 7 Standard of Care 7 Filgrastim 7 Everolimus 7 Etoposide 7 Drug Therapy 7 ribociclib 6 Proton Therapy 6 Lomustine 6 Imatinib Mesylate 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01700569 2023-02-21

FOLAGLI

Institut Cancerologie de l'Ouest

Phase 1 Terminated

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡